Boston Scientific Announces Conference Call Discussing Second Quarter 2020 Financial Results

MARLBOROUGH, Mass., June 30, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2020 on Wednesday, July 29, 2020 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the second quarter on Wednesday, July 29, 2020, prior to the conference call.

A live webcast of the conference call will be available on the Investor Relations section of the website at investors.bostonscientific.com.

A replay of the webcast will be archived and available at investors.bostonscientific.com beginning approximately one hour following the completion of the meeting.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.


     
              CONTACTS



     Media:                          
     Investors:



     Katie Schur                     
     Susie Lisa, CFA



     508-683-5574 (office)           
     508-683-5565 (office)



     Media Relations                 
     Investor Relations



     Boston Scientific Corporation   
     Boston Scientific Corporation



     
              Katie.Schur@bsci.com 
     
              BSXInvestorRelations@bsci.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-second-quarter-2020-financial-results-301085765.html

SOURCE Boston Scientific Corporation